Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.60 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.60 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.60 |
| ▸ | MEN1 | O00255 | 5/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.59 |
| ▸ | HPGD | P15428 | 2/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.59 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 3/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | ADORA1 | P30542 | 3/20 | 0.48 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.48 |
| ▸ | CTRC | Q99895 | 1/20 | 0.47 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.46 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.45 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26626435 | 0.98 | KDM4E (0.58) | KDM4EHSP90AA1HSP90AB1MEN1KMT2A | |
| SCHEMBL30436540 | 0.94 | KDM4E (0.55) | KDM4EHSP90AA1HSP90AB1MEN1KMT2A | |
| SCHEMBL20889210 | 0.94 | KDM4E (0.55) | KDM4EHSP90AA1HSP90AB1MEN1KMT2A | |
| SCHEMBL20918236 | 0.92 | CTRC (0.58) | KDM4EHSP90AA1HSP90AB1MEN1KMT2A | |
| SCHEMBL24212277 | 0.89 | L3MBTL1 (0.53) | KDM4EHSP90AA1HSP90AB1MEN1KMT2A | |
| SCHEMBL28331410 | 0.86 | KDM4E (0.47) | KDM4EHSP90AA1HSP90AB1MEN1KMT2A | |
| SCHEMBL4000527 | 0.86 | KDM4E (0.52) | KDM4EHSP90AA1HSP90AB1MEN1KMT2A | |
| SCHEMBL20396108 | 0.84 | CYP1A2 (0.52) | KDM4EHSP90AA1HSP90AB1MEN1KMT2A | |
| SCHEMBL30032338 | 0.84 | KDM4E (0.49) | KDM4EHSP90AA1HSP90AB1MEN1KMT2A | |
| SCHEMBL960513 | 0.84 | CYP19A1 (0.65) | MEN1KMT2AALDH1A1HPGDL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 248 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250324848-A1 | LIGHT-EMITTING DEVICE, AND ELECTRONIC APPARATUS AND ELECTRONIC EQUIPMENT INCLUDING THE SAME | SAMSUNG DISPLAY CO LTD (KR) | 2025-10-16 | — | — | US | disclosed |
| US-20250212685-A1 | LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND THE HETEROCYCLIC COMPOUND | SAMSUNG DISPLAY CO., LTD. (KR) | 2025-06-26 | — | — | US | disclosed |
| US-20250143170-A1 | HETEROCYCLIC COMPOUND AND LIGHT-EMITTING DEVICE USING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2025-05-01 | — | — | US | disclosed |
| CN-119899208-A | Heterocyclic compound, light-emitting device including the same, and electronic apparatus and electronic device including the light-emitting device | 三星显示有限公司 | 2025-04-29 | — | — | CN | disclosed |
| US-11968897-B2 | Heterocyclic compound and organic light emitting diode containing same | LG CHEM, LTD. (KR) | 2024-04-23 | — | — | US | disclosed |
| EP-3378853-B1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | LG CHEMICAL LTD (KR) | 2024-04-17 | — | — | EP | disclosed |
| CN-112088158-B | Compound and organic light emitting device comprising the same | 株式会社LG化学 | 2024-03-08 | — | — | CN | disclosed |
| WO-2023160187-A1 | CARBAZOLE DERIVATIVE AND USE THEREOF | 上海八亿时空先进材料有限公司 | 2023-08-31 | — | — | WO | disclosed |
| US-11730009-B2 | Compound and organic light-emitting element comprising same | LG CHEM, LTD. | 2023-08-15 | — | — | US | disclosed |
| US-11730009-B2 | Compound and organic light-emitting element comprising same | LG CHEM, LTD. | 2023-08-15 | — | — | US | disclosed |
| US-5635197-A | BENZO(F)QUINOLIN-3-ONES; ANTICARCINOGENIC AGENTS; BONE DISORDERS | ELI LILLY AND COMPANY (US) | 1997-06-03 | — | — | US | disclosed |
| US-5629007-A | USING BENZOQUINOLIN-3-ONE DERIVATIVES | ELI LILLY AND COMPANY (US) | 1997-05-13 | — | — | US | disclosed |
| US-5622961-A | PROSTATE CANCER, SKIN DISORDERS, BALDNESS | ELI LILLY AND COMPANY (US) | 1997-04-22 | — | — | US | disclosed |
| US-5622962-A | PROSTATE CANCER, SKIN DISORDERS, BALDNESS | ELI LILLY AND COMPANY (US) | 1997-04-22 | — | — | US | disclosed |
| CN-1138458-A | Treatment and prevention of prostatic cancer | LILLY CO ELI (US) | 1996-12-25 | — | — | CN | disclosed |
| US-5578724-A | INHIBITORS OF 5-ALPHA-REDUCTASE | ELI LILLY AND COMPANY (US) | 1996-11-26 | — | — | US | disclosed |
| WO-1996035422-A1 | METHODS FOR INHIBITING BONE LOSS | ELI LILLY AND COMPANY (US) | 1996-11-14 | — | — | WO | disclosed |
| EP-0742010-A2 | Benzoquinolin-3-ones to inhibit bone loss | ELI LILLY AND COMPANY (US) | 1996-11-13 | — | — | EP | disclosed |
| EP-0733365-A2 | Use of benzoquinolin-3-ones for the treatment and prevention of prostatic cancer | ELI LILLY AND COMPANY (US) | 1996-09-25 | — | — | EP | disclosed |
| US-5550134-A | ADMINISTERING TO A MAMMAL FROM A SERIES OF BENZOQUINOLIN-3-ONE COMPOUNDS | ELI LILLY AND COMPANY (US) | 1996-08-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250143170-A1 | HETEROCYCLIC COMPOUND AND LIGHT-EMITTING DEVICE USING THE SAME | CRY1, CYP1A1, NQO1 | KDM4E 3637/4885HSP90AA1 3610/4885HSP90AB1 4199/4885 |
| US-11730009-B2 | Compound and organic light-emitting element comprising same | CRY2, CRY1, NR2E3 | KDM4E 1661/4885HSP90AA1 4778/4885HSP90AB1 4852/4885 |
| US-11968897-B2 | Heterocyclic compound and organic light emitting diode containing same | CRY1, CCNT1, CYP1A1 | KDM4E 2807/4885HSP90AA1 4615/4885HSP90AB1 4732/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.